Cargando…
Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
Necroptosis is a new type of programmed cell death and involves the occurrence and development of various cancers. Moreover, the aberrantly expressed lncRNA can also affect tumorigenesis, migration, and invasion. However, there are few types of research on the necroptosis-related lncRNA (NRL), espec...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818734/ https://www.ncbi.nlm.nih.gov/pubmed/36611858 http://dx.doi.org/10.3390/cells12010066 |
_version_ | 1784865059104620544 |
---|---|
author | Zhang, Yue Zhuang, Tongtian Xin, Zhenlong Sun, Changjian Li, Deyang Ma, Nan Wang, Xiaoyan Wang, Xuning |
author_facet | Zhang, Yue Zhuang, Tongtian Xin, Zhenlong Sun, Changjian Li, Deyang Ma, Nan Wang, Xiaoyan Wang, Xuning |
author_sort | Zhang, Yue |
collection | PubMed |
description | Necroptosis is a new type of programmed cell death and involves the occurrence and development of various cancers. Moreover, the aberrantly expressed lncRNA can also affect tumorigenesis, migration, and invasion. However, there are few types of research on the necroptosis-related lncRNA (NRL), especially in kidney renal clear cell carcinoma (KIRC). In this study, we analyzed the sequencing data obtained from the TGCA-KIRC dataset, then applied the LASSO and COX analysis to identify 6 NRLs (AC124854.1, AL117336.1, DLGAP1-AS2, EPB41L4A-DT, HOXA-AS2, and LINC02100) to construct a risk model. Patients suffering from KIRC were divided into high- and low-risk groups according to the risk score, and the patients in the low-risk group had a longer OS. This signature can be used as an indicator to predict the prognosis of KIRC independent of other clinicopathological features. In addition, the gene set enrichment analysis showed that some tumor and immune-associated pathways were more enriched in a high-risk group. We also found significant differences between the high and low-risk groups in the infiltrating immune cells, immune functions, and expression of immune checkpoint molecules. Finally, we use the “pRRophetic” package to complete the drug sensitivity prediction, and the risk score could reflect patients’ response to 8 small molecule compounds. In general, NRLs divided KIRC into two subtypes with different risk scores. Furthermore, this signature based on the 6 NRLs could provide a promising method to predict the prognosis and immune response of KIRC patients. To some extent, our findings helped give a reference for further research between NRLs and KIRC and find more effective therapeutic drugs for KIRC. |
format | Online Article Text |
id | pubmed-9818734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98187342023-01-07 Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma Zhang, Yue Zhuang, Tongtian Xin, Zhenlong Sun, Changjian Li, Deyang Ma, Nan Wang, Xiaoyan Wang, Xuning Cells Article Necroptosis is a new type of programmed cell death and involves the occurrence and development of various cancers. Moreover, the aberrantly expressed lncRNA can also affect tumorigenesis, migration, and invasion. However, there are few types of research on the necroptosis-related lncRNA (NRL), especially in kidney renal clear cell carcinoma (KIRC). In this study, we analyzed the sequencing data obtained from the TGCA-KIRC dataset, then applied the LASSO and COX analysis to identify 6 NRLs (AC124854.1, AL117336.1, DLGAP1-AS2, EPB41L4A-DT, HOXA-AS2, and LINC02100) to construct a risk model. Patients suffering from KIRC were divided into high- and low-risk groups according to the risk score, and the patients in the low-risk group had a longer OS. This signature can be used as an indicator to predict the prognosis of KIRC independent of other clinicopathological features. In addition, the gene set enrichment analysis showed that some tumor and immune-associated pathways were more enriched in a high-risk group. We also found significant differences between the high and low-risk groups in the infiltrating immune cells, immune functions, and expression of immune checkpoint molecules. Finally, we use the “pRRophetic” package to complete the drug sensitivity prediction, and the risk score could reflect patients’ response to 8 small molecule compounds. In general, NRLs divided KIRC into two subtypes with different risk scores. Furthermore, this signature based on the 6 NRLs could provide a promising method to predict the prognosis and immune response of KIRC patients. To some extent, our findings helped give a reference for further research between NRLs and KIRC and find more effective therapeutic drugs for KIRC. MDPI 2022-12-23 /pmc/articles/PMC9818734/ /pubmed/36611858 http://dx.doi.org/10.3390/cells12010066 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Yue Zhuang, Tongtian Xin, Zhenlong Sun, Changjian Li, Deyang Ma, Nan Wang, Xiaoyan Wang, Xuning Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma |
title | Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma |
title_full | Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma |
title_fullStr | Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma |
title_full_unstemmed | Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma |
title_short | Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma |
title_sort | construction of a necroptosis-related lncrna signature for predicting prognosis and immune response in kidney renal clear cell carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818734/ https://www.ncbi.nlm.nih.gov/pubmed/36611858 http://dx.doi.org/10.3390/cells12010066 |
work_keys_str_mv | AT zhangyue constructionofanecroptosisrelatedlncrnasignatureforpredictingprognosisandimmuneresponseinkidneyrenalclearcellcarcinoma AT zhuangtongtian constructionofanecroptosisrelatedlncrnasignatureforpredictingprognosisandimmuneresponseinkidneyrenalclearcellcarcinoma AT xinzhenlong constructionofanecroptosisrelatedlncrnasignatureforpredictingprognosisandimmuneresponseinkidneyrenalclearcellcarcinoma AT sunchangjian constructionofanecroptosisrelatedlncrnasignatureforpredictingprognosisandimmuneresponseinkidneyrenalclearcellcarcinoma AT lideyang constructionofanecroptosisrelatedlncrnasignatureforpredictingprognosisandimmuneresponseinkidneyrenalclearcellcarcinoma AT manan constructionofanecroptosisrelatedlncrnasignatureforpredictingprognosisandimmuneresponseinkidneyrenalclearcellcarcinoma AT wangxiaoyan constructionofanecroptosisrelatedlncrnasignatureforpredictingprognosisandimmuneresponseinkidneyrenalclearcellcarcinoma AT wangxuning constructionofanecroptosisrelatedlncrnasignatureforpredictingprognosisandimmuneresponseinkidneyrenalclearcellcarcinoma |